Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 2
2007 1
2008 6
2009 2
2010 4
2011 1
2012 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.
Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI. Corzo CA, et al. J Exp Med. 2010 Oct 25;207(11):2439-53. doi: 10.1084/jem.20100587. Epub 2010 Sep 27. J Exp Med. 2010. PMID: 20876310 Free PMC article.
Peptide epitope identification for tumor-reactive CD4 T cells.
Kobayashi H, Celis E. Kobayashi H, et al. Curr Opin Immunol. 2008 Apr;20(2):221-7. doi: 10.1016/j.coi.2008.04.011. Epub 2008 May 20. Curr Opin Immunol. 2008. PMID: 18499419 Free PMC article. Review.
Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R, Celis E. Kennedy R, et al. Immunol Rev. 2008 Apr;222:129-44. doi: 10.1111/j.1600-065X.2008.00616.x. Immunol Rev. 2008. PMID: 18363998 Review.
Interferon γ limits the effectiveness of melanoma peptide vaccines.
Cho HI, Lee YR, Celis E. Cho HI, et al. Blood. 2011 Jan 6;117(1):135-44. doi: 10.1182/blood-2010-08-298117. Epub 2010 Oct 1. Blood. 2011. PMID: 20889921 Free PMC article.
Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy.
Ramakrishnan R, Huang C, Cho HI, Lloyd M, Johnson J, Ren X, Altiok S, Sullivan D, Weber J, Celis E, Gabrilovich DI. Ramakrishnan R, et al. Cancer Res. 2012 Nov 1;72(21):5483-93. doi: 10.1158/0008-5472.CAN-12-2236. Epub 2012 Aug 31. Cancer Res. 2012. PMID: 22942258 Free PMC article.
Focal adhesion kinase as an immunotherapeutic target.
Kobayashi H, Azumi M, Kimura Y, Sato K, Aoki N, Kimura S, Honma M, Iizuka H, Tateno M, Celis E. Kobayashi H, et al. Cancer Immunol Immunother. 2009 Jun;58(6):931-40. doi: 10.1007/s00262-008-0608-0. Epub 2008 Oct 22. Cancer Immunol Immunother. 2009. PMID: 18941742 Free PMC article.
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.
Ramakrishnan R, Assudani D, Nagaraj S, Hunter T, Cho HI, Antonia S, Altiok S, Celis E, Gabrilovich DI. Ramakrishnan R, et al. J Clin Invest. 2010 Apr;120(4):1111-24. doi: 10.1172/JCI40269. Epub 2010 Mar 15. J Clin Invest. 2010. PMID: 20234093 Free PMC article.
Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors.
Lee S, Yagita H, Sayers TJ, Celis E. Lee S, et al. Cancer Immunol Immunother. 2010 Jul;59(7):1073-81. doi: 10.1007/s00262-010-0834-0. Epub 2010 Mar 6. Cancer Immunol Immunother. 2010. PMID: 20213120 Free PMC article.
T helper lymphocytes rescue CTL from activation-induced cell death.
Kennedy R, Celis E. Kennedy R, et al. J Immunol. 2006 Sep 1;177(5):2862-72. doi: 10.4049/jimmunol.177.5.2862. J Immunol. 2006. PMID: 16920921 Free PMC article.
Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects.
Cho HI, Celis E. Cho HI, et al. Cancer Res. 2009 Dec 1;69(23):9012-9. doi: 10.1158/0008-5472.CAN-09-2019. Epub 2009 Nov 10. Cancer Res. 2009. PMID: 19903852 Free PMC article.
18 results
Jump to page
Feedback